Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2022

01-05-2021 | Endoscopy | Original Article

Gastrointestinal Computed Tomography Findings in Chronic Granulomatous Disease with Subgroup Clinicopathologic Analysis

Authors: Sumona Bhattacharya, Yilun Koethe, Alexander Ling, Natasha Kamal, Sajneet Khangura, Meghna Alimchandani, Martha M. Quezado, Christa S. Zerbe, Harry L. Malech, John I. Gallin, Steven M. Holland, Theo Heller, Elizabeth Jones, Aradhana M. Venkatesan

Published in: Digestive Diseases and Sciences | Issue 5/2022

Login to get access

Abstract

Background

Chronic granulomatous disease (CGD) is a rare primary immunodeficiency which can lead to gastrointestinal (GI) complications including inflammatory bowel disease. Radiographic findings in this cohort have not been well described.

Aims

To describe the frequency and spectrum of gastrointestinal abnormalities seen on computed tomography (CT) in patients with CGD and determine whether radiography was predictive of endoscopic or histopathologic inflammatory findings.

Methods

A retrospective review was conducted on 141 consecutive CGD patients seen at the National Institutes of Health between 1988 and 2011. All corresponding CTs were reviewed for gastrointestinal abnormalities including wall thickening. Endoscopic and histopathologic findings were reviewed in subjects with documented endoscopy within 30 days of an imaging study. Findings were compared between patients with and without wall thickening on CT to determine whether bowel wall thickening was predictive of endoscopic or histologic inflammatory findings.

Results

Two hundred and ninety-two CTs were reviewed. GI wall thickening was present on CT in 61% of patients (n = 86). Among a subgroup of 20 patients who underwent endoscopy at the time of their imaging, there was a statistically significant correlation between radiographic gastrointestinal wall thickening and endoscopic inflammation in the same intestinal segment (p = 0.035). Additionally, there was a significant correlation between radiographic gastrointestinal wall thickening and inflammatory features on histopathology (p = 0.02).

Conclusions

GI abnormalities are commonly observed on CT in CGD patients. Bowel wall thickening correlates with endoscopic and histopathologic evidence of inflammation. These findings may be used to better facilitate directed endoscopic assessment and histopathologic sampling in patients with CGD.
Literature
1.
go back to reference Winkelstein JA, Marino MC, Johnston RB Jr et al. Chronic granulomatous diseas.e Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–169.CrossRef Winkelstein JA, Marino MC, Johnston RB Jr et al. Chronic granulomatous diseas.e Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–169.CrossRef
2.
go back to reference Kuhns DB, Alvord WG, Heller T et al. Residual NADPH oxidase and survival in chronic granulomatous disease. New Engl J Med. 2010;363:2600–2610.CrossRef Kuhns DB, Alvord WG, Heller T et al. Residual NADPH oxidase and survival in chronic granulomatous disease. New Engl J Med. 2010;363:2600–2610.CrossRef
3.
go back to reference Holland SM. Chronic granulomatous disease. Hematol/Oncol Clin N Am. 2013;27:89–99.CrossRef Holland SM. Chronic granulomatous disease. Hematol/Oncol Clin N Am. 2013;27:89–99.CrossRef
4.
go back to reference Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170–200.CrossRef Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170–200.CrossRef
5.
go back to reference Garcia-Eulate R, Hussain N, Heller T et al. CT and MRI of hepatic abscess in patients with chronic granulomatous disease. AJR Am J Roentgenol. 2006;187:482–490.CrossRef Garcia-Eulate R, Hussain N, Heller T et al. CT and MRI of hepatic abscess in patients with chronic granulomatous disease. AJR Am J Roentgenol. 2006;187:482–490.CrossRef
6.
go back to reference Towbin AJ, Chaves I. Chronic granulomatous disease. Pediatric Radiol 2010;40:657–668 (quiz 792-3).CrossRef Towbin AJ, Chaves I. Chronic granulomatous disease. Pediatric Radiol 2010;40:657–668 (quiz 792-3).CrossRef
7.
go back to reference Marciano BE, Rosenzweig SD, Kleiner DE et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462–468.CrossRef Marciano BE, Rosenzweig SD, Kleiner DE et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462–468.CrossRef
8.
go back to reference Marks DJ, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn’s disease. Am J Gastroenterol. 2009;104:117–124.CrossRef Marks DJ, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn’s disease. Am J Gastroenterol. 2009;104:117–124.CrossRef
9.
go back to reference Alimchandani M, Lai JP, Aung PP et al. Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol. 2013;37:1365–1372.CrossRef Alimchandani M, Lai JP, Aung PP et al. Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol. 2013;37:1365–1372.CrossRef
10.
go back to reference Angelino G, De Angelis P, Faraci S, F et al. Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years’ experience. Pediatr Allergy Immunol. 2017;28:801–809.CrossRef Angelino G, De Angelis P, Faraci S, F et al. Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years’ experience. Pediatr Allergy Immunol. 2017;28:801–809.CrossRef
11.
go back to reference Kamal N, Marciano B, Curtin B et al. The response to vedolizumab in chronic granulomatous disease-related inflammatory bowel disease. Gastroenterol Rep. 2020;8:404.CrossRef Kamal N, Marciano B, Curtin B et al. The response to vedolizumab in chronic granulomatous disease-related inflammatory bowel disease. Gastroenterol Rep. 2020;8:404.CrossRef
12.
go back to reference Hahn KJ, Ho N, Yockey L et al. Treatment with Anakinra, a recombinant IL-1 receptor antagonist, unlikely to induce lasting remission in patients With CGD colitis. Am J Gastroenterol. 2015;110:938–939.CrossRef Hahn KJ, Ho N, Yockey L et al. Treatment with Anakinra, a recombinant IL-1 receptor antagonist, unlikely to induce lasting remission in patients With CGD colitis. Am J Gastroenterol. 2015;110:938–939.CrossRef
13.
go back to reference Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010;51:1429–1434.CrossRef Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010;51:1429–1434.CrossRef
14.
go back to reference Alvarez-Downing MM, Kamal N, Inchauste SM et al. The role of surgery in the management of patients with refractory chronic granulomatous disease colitis. Dis Colon Rectum. 2013;56:609–614.CrossRef Alvarez-Downing MM, Kamal N, Inchauste SM et al. The role of surgery in the management of patients with refractory chronic granulomatous disease colitis. Dis Colon Rectum. 2013;56:609–614.CrossRef
15.
go back to reference Marsh RA, Leiding JW, Logan BR et al. Chronic Granulomatous Disease-associated IBD resolves and does not adversely impact survival following allogeneic HCT. J Clin Immunol. 2019;39:653–667.CrossRef Marsh RA, Leiding JW, Logan BR et al. Chronic Granulomatous Disease-associated IBD resolves and does not adversely impact survival following allogeneic HCT. J Clin Immunol. 2019;39:653–667.CrossRef
16.
go back to reference Feld JJ, Hussain N, Wright EC et al. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology 2008;134:1917–1926.CrossRef Feld JJ, Hussain N, Wright EC et al. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology 2008;134:1917–1926.CrossRef
17.
go back to reference Godoy MC, Vos PM, Cooperberg PL, Lydell CP, Phillips P, Müller NL. Chest radiographic and CT manifestations of chronic granulomatous disease in adults. AJR Am J Roentgenol. 2008;191:1570–1575.CrossRef Godoy MC, Vos PM, Cooperberg PL, Lydell CP, Phillips P, Müller NL. Chest radiographic and CT manifestations of chronic granulomatous disease in adults. AJR Am J Roentgenol. 2008;191:1570–1575.CrossRef
18.
go back to reference Lee M, Lee MS, Lee JS, Ko SY, Jeong SY. Spectrum of imaging findings of chronic granulomatous disease: a single center experience. Diagn Interv Radiolgy (Ankara, Turkey). 2017;23:472–477.CrossRef Lee M, Lee MS, Lee JS, Ko SY, Jeong SY. Spectrum of imaging findings of chronic granulomatous disease: a single center experience. Diagn Interv Radiolgy (Ankara, Turkey). 2017;23:472–477.CrossRef
19.
go back to reference Xia F, Mao J, Ding J, Yang H. Observation of normal appearance and wall thickness of esophagus on CT images. Eur J Radiol 2009;72:406–411.CrossRef Xia F, Mao J, Ding J, Yang H. Observation of normal appearance and wall thickness of esophagus on CT images. Eur J Radiol 2009;72:406–411.CrossRef
20.
go back to reference Karahan OI, Dodd GD 3rd, Chintapalli KN, Rhim H, Chopra S. Gastrointestinal wall thickening in patients with cirrhosis: frequency and patterns at contrast-enhanced CT. Radiology. 2000;215:103–107.CrossRef Karahan OI, Dodd GD 3rd, Chintapalli KN, Rhim H, Chopra S. Gastrointestinal wall thickening in patients with cirrhosis: frequency and patterns at contrast-enhanced CT. Radiology. 2000;215:103–107.CrossRef
21.
go back to reference Wiesner W, Mortele KJ, Ji H, Ros PR. Normal colonic wall thickness at CT and its relation to colonic distension. J Comput Assist Tomogr. 2002;26:102–106.CrossRef Wiesner W, Mortele KJ, Ji H, Ros PR. Normal colonic wall thickness at CT and its relation to colonic distension. J Comput Assist Tomogr. 2002;26:102–106.CrossRef
22.
go back to reference Horton KM, Corl FM, Fishman EK. CT evaluation of the colon: inflammatory disease. Radiographics. 2000;20:399–418.CrossRef Horton KM, Corl FM, Fishman EK. CT evaluation of the colon: inflammatory disease. Radiographics. 2000;20:399–418.CrossRef
23.
go back to reference Macari M, Balthazar EJ. CT of bowel wall thickening: significance and pitfalls of interpretation. AJR Am J Roentgenol. 2001;176:1105–1116.CrossRef Macari M, Balthazar EJ. CT of bowel wall thickening: significance and pitfalls of interpretation. AJR Am J Roentgenol. 2001;176:1105–1116.CrossRef
24.
go back to reference Laskey HL, Gopal L, Gallin JI, Holland SM, Heller T. Twenty-year follow-up of esophageal involvement in chronic granulomatous disease. Am J Gastroenterol. 2009;104:2368–2370.CrossRef Laskey HL, Gopal L, Gallin JI, Holland SM, Heller T. Twenty-year follow-up of esophageal involvement in chronic granulomatous disease. Am J Gastroenterol. 2009;104:2368–2370.CrossRef
25.
go back to reference Golioto M, O’Connor JB. Esophageal dysmotility in an adult with chronic granulomatous disease. J Clin Gastroenterol 2001;33:330–332.CrossRef Golioto M, O’Connor JB. Esophageal dysmotility in an adult with chronic granulomatous disease. J Clin Gastroenterol 2001;33:330–332.CrossRef
26.
go back to reference Khanna G, Kao SC, Kirby P, Sato Y. Imaging of chronic granulomatous disease in children. Radiographics. 2005;25:1183–1195.CrossRef Khanna G, Kao SC, Kirby P, Sato Y. Imaging of chronic granulomatous disease in children. Radiographics. 2005;25:1183–1195.CrossRef
27.
go back to reference Khangura SK, Kamal N, Ho N et al. Gastrointestinal features of chronic granulomatous disease found during endoscopy. Clin Gastroenterol Hepatol. 2016;14:395–402.CrossRef Khangura SK, Kamal N, Ho N et al. Gastrointestinal features of chronic granulomatous disease found during endoscopy. Clin Gastroenterol Hepatol. 2016;14:395–402.CrossRef
28.
go back to reference Goldblatt D. Recent advances in chronic granulomatous disease. The Journal of infection. 2014;69:S32–S35.CrossRef Goldblatt D. Recent advances in chronic granulomatous disease. The Journal of infection. 2014;69:S32–S35.CrossRef
29.
go back to reference Huang A, Abbasakoor F, Vaizey CJ. Gastrointestinal manifestations of chronic granulomatous disease. Colorectal Dis Off J Assoc Coloproctol G B Irel 2006;8:637–644. Huang A, Abbasakoor F, Vaizey CJ. Gastrointestinal manifestations of chronic granulomatous disease. Colorectal Dis Off J Assoc Coloproctol G B Irel 2006;8:637–644.
30.
go back to reference Schappi MG, Klein NJ, Lindley KJ et al. The nature of colitis in chronic granulomatous disease. J Pediatric Gastroenterol Nutr. 2003;36:623–631.CrossRef Schappi MG, Klein NJ, Lindley KJ et al. The nature of colitis in chronic granulomatous disease. J Pediatric Gastroenterol Nutr. 2003;36:623–631.CrossRef
31.
go back to reference Hong SS, Kim AY, Byun JH et al. MDCT of small-bowel disease: value of 3D imaging. AJR Am J Roentgenol. 2006;187:1212–1221.CrossRef Hong SS, Kim AY, Byun JH et al. MDCT of small-bowel disease: value of 3D imaging. AJR Am J Roentgenol. 2006;187:1212–1221.CrossRef
32.
go back to reference Gopal L, Forbes J, Uzel G, Holland SM, Heller T. Gastrointestinal fistulae in chronic granulomatous disease. Am J Gastroenterol. 2009;104:2112–2113.CrossRef Gopal L, Forbes J, Uzel G, Holland SM, Heller T. Gastrointestinal fistulae in chronic granulomatous disease. Am J Gastroenterol. 2009;104:2112–2113.CrossRef
33.
go back to reference Macari M, Megibow AJ, Balthazar EJ. A pattern approach to the abnormal small bowel: observations at MDCT and CT enterography. AJR Am J Roentgenol. 2007;188:1344–1355.CrossRef Macari M, Megibow AJ, Balthazar EJ. A pattern approach to the abnormal small bowel: observations at MDCT and CT enterography. AJR Am J Roentgenol. 2007;188:1344–1355.CrossRef
Metadata
Title
Gastrointestinal Computed Tomography Findings in Chronic Granulomatous Disease with Subgroup Clinicopathologic Analysis
Authors
Sumona Bhattacharya
Yilun Koethe
Alexander Ling
Natasha Kamal
Sajneet Khangura
Meghna Alimchandani
Martha M. Quezado
Christa S. Zerbe
Harry L. Malech
John I. Gallin
Steven M. Holland
Theo Heller
Elizabeth Jones
Aradhana M. Venkatesan
Publication date
01-05-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06978-4

Other articles of this Issue 5/2022

Digestive Diseases and Sciences 5/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.